Gobernanza Pfizer, Inc.

PFE

US7170811035

Farmacéuticos

Mercado cerrado - Nyse Otros sitios de cotización 22:00:02 24/01/2025			Varia. Cinco días.	Varia. 1 de enero.
26,09 ^USD	+0,31 %		-0,80 %	-1,66 %

24/01	Pfizer pagará 59,7 millones de dólares por las comisiones ilegales de un medicamento contra la migraña	RE
17/01	Ozempic y Wegovy, de Novo Nordisk, entre los fármacos elegidos para las negociaciones sobre precios de Medicare en EE.UU.	MT

Comité Ejecutivo: Pfizer, Inc.

Director

Funciones ocupadasDesde

Albert Bourla

63 años

Chief Executive Officer

01/01/2019

Douglas Lankler

59 años

General Counsel

01/12/2013

Aida Habtezion

Chief Tech/Sci/R&D Officer

01/01/2021

Gordon Loh

Comptroller/Controller/Auditor

01/03/2020

Jennifer Damico

57 años

Comptroller/Controller/Auditor

01/03/2020

Lidia Fonseca

56 años

Chief Tech/Sci/R&D Officer

François-Maurice Garnier

62 años

General Counsel

01/01/2003

Margaret M. Madden

General Counsel	-
Corporate Secretary	-

Rady Johnson

64 años

Compliance Officer

01/12/2013

Bryan Supran

General Counsel

01/04/2016

Christopher J. Stevo

Investor Relations Contact

19/07/2021

Susan Rienow

46 años

Sales & Marketing

01/07/2024

Chris Boshoff

Chief Tech/Sci/R&D Officer

01/01/2025

Maria Rivas

61 años

Chief Tech/Sci/R&D Officer

01/09/2022

Annaliesa Anderson

Chief Tech/Sci/R&D Officer

01/01/2007

David Denton

60 años

Director of Finance/CFO

02/05/2022

Payal Sahni Becher

Human Resources Officer

01/01/1997

Composición del Consejo de Administración: Pfizer, Inc.

Administrador

ComitésDesde

Albert Bourla

63 años

Executive Committee Chair

01/01/2020

Scott Gottlieb

52 años

Executive Committee	27/06/2019
Governance Committee	29/10/2019
Nominating Committee	29/10/2019
Compensation Committee	04/02/2020
Governance Committee Chair	04/02/2020
Nominating Committee Chair	04/02/2020

Ronald Blaylock

65 años

Compensation Committee	23/02/2017
Governance Committee	01/01/2001
Nominating Committee	01/01/2001
Compensation Committee Chair	17/10/2007
HR Committee Chair	17/10/2007
Audit Committee	23/02/2017

Joseph Echevarria

67 años

Audit Committee	25/06/2015
Governance Committee	01/04/2016
Nominating Committee
Finance Committee Chair
Executive Committee	25/06/2015
Governance Committee Chair	25/06/2015

Suzanne Johnson

67 años

Executive Committee	01/09/2007
Audit Committee Chair	01/09/2007
Governance Committee	20/01/2022
Nominating Committee	20/01/2022
Compensation Committee Chair	20/01/2022

Mortimer Joseph Buckley

Audit Committee	15/10/2024
Governance Committee	01/01/2025
Finance Committee	01/01/2025

Cyrus Taraporevala

59 años

Audit Committee	27/06/2024
Compensation Committee	27/06/2024
Nominating Committee	14/12/2023

Jim Smith

65 años

Audit Committee	26/06/2014
Executive Committee	26/06/2014
Compensation Committee Chair	26/06/2014

Helen Hobbs

72 años

Executive Committee	12/12/2011
Governance Committee	18/04/2012

James Quincey

60 años

Executive Committee Chair	24/04/2019
Compensation Committee	27/02/2020

Sue Desmond-Hellmann

67 años

Governance Committee

01/01/2020

Shantanu Narayen

61 años

Executive Committee

27/09/2013

Dan Littman

72 años

Governance Committee

05/03/2018

Susan Hockfield

74 años

Director/Board Member	04/03/2020
Independent Dir/Board Member	04/03/2020

Últimos Nombramientos: Pfizer, Inc.

Las acciones de Arvinas caen ante la actualización del ensayo de un fármaco contra el cáncer de mama y la salida del CCO	10/01	MT
Annexon, Inc. nombra a William ?BJ? Jones a su Consejo de Administración	10/01	CI
Principales caídas del mediodía	24/12	MT
Aadi Bioscience, Inc. nombra a Baiteng Zhao miembro de su Consejo de Administración	20/12	CI
Akari Therapeutics, Plc anuncia cambios en su Junta Directiva	18/12	CI
Haleon dice que el representante de Pfizer abandona el consejo	05/12	AN

Más noticias

Antiguos Directivos y Administradores: Pfizer, Inc.

Insider

Funciones ocupadas

DesdeHasta

Frank D'Amelio

Director of Finance/CFO	01/09/2007	01/06/2020
Corporate Officer/Principal	01/06/2020	01/12/2021

James Kilts

Director/Board Member	01/09/2007	16/11/2020
Independent Dir/Board Member	01/09/2007	16/11/2020

Wyllie Cornwell

Director/Board Member	01/02/1997	16/11/2020
Independent Dir/Board Member	01/02/1997	16/11/2020

Loretta V. Cangialosi

Comptroller/Controller/Auditor

01/03/2020

Dennis Ausiello

Director/Board Member	01/12/2006	25/04/2019
Chairman	25/05/2011	25/05/2011
Independent Dir/Board Member	23/04/2015	25/04/2019

George A. Lorch

Director/Board Member	01/06/2000	23/04/2015
Chairman	14/12/2010	13/12/2011
Independent Dir/Board Member	05/04/2011	23/04/2015

M. Anthony Burns

Director/Board Member	01/01/1988	19/12/2013
Independent Dir/Board Member	24/05/2011	19/12/2013

William Herbert Gray

Director/Board Member	01/06/2000	01/07/2013
Independent Dir/Board Member	24/05/2011	01/07/2013

Michael Brown

Director/Board Member	01/01/1996	01/04/2012
Independent Dir/Board Member	24/05/2011	01/04/2012

Briggs Morrison

Chief Tech/Sci/R&D Officer

01/10/2007

01/12/2011

Neil Gibson

Corporate Officer/Principal

01/01/2007

01/01/2011

Jeffrey Kindler

Director/Board Member	01/03/2005	31/07/2006
Chief Executive Officer	31/07/2006	05/12/2010
Chairman	19/12/2006	05/12/2010
General Counsel	01/01/2002	31/07/2006
Corporate Officer/Principal	01/01/2002	01/03/2005

Richard Bagger

Public Communications Contact

01/01/2006

01/01/2010

John LaMattina

Corporate Officer/Principal

01/01/2004

01/12/2008

Allen Waxman

General Counsel

01/01/2003

11/03/2008

David Shedlarz

Director/Board Member	01/07/2005	01/12/2007
Director of Finance/CFO	01/01/1999	01/07/2005
Corporate Officer/Principal	01/07/2005	01/12/2007

Alan Levin

Director of Finance/CFO	01/01/1987	01/09/2007
Treasurer	01/01/1987	01/09/2007

Ruth Simmons

Director/Board Member

01/01/1997

26/04/2007

Stanley O. Ikenberry

Director/Board Member

01/10/2005

22/03/2007

Karen Katen

Director/Board Member

01/01/1974

01/01/2007

Eliot Forster

Corporate Officer/Principal

01/01/1996

01/01/2007

Sharon Real

Corporate Officer/Principal

01/01/2000

01/01/2006

Jean-Paul Vallès

Director/Board Member

01/01/1980

23/06/2005

Yvonne R. Jackson

Human Resources Officer

01/07/2002

01/06/2005

Franklin Raines

Director/Board Member	01/10/1998	28/04/2005
Director/Board Member	01/01/1993	01/01/1996

Yoshihiro Toyohara

Corporate Officer/Principal

01/01/2003

01/01/2005

Brian Goldberg

Corporate Officer/Principal

01/06/2002

30/09/2004

William J. Creelman

Comptroller/Controller/Auditor

01/01/2003

01/01/2004

Lynne E. Weissberger

Director/Board Member

01/04/1996

01/12/2003

William H. D. Horton

Public Communications Contact

01/07/2002

01/09/2003

Pat Parr

Corporate Officer/Principal

01/01/1997

01/04/2003

George Milne

Director/Board Member	01/01/1984	01/01/1985
Chief Tech/Sci/R&D Officer	01/01/1970	01/01/2002

Warren R. Winter

Chief Tech/Sci/R&D Officer

01/01/1986

31/12/2001

Emmett Cunningham

Corporate Officer/Principal

31/12/2001

Wendell Wierenga

Corporate Officer/Principal

01/01/1990

01/07/2000

Michael Berendt

Corporate Officer/Principal

01/01/1982

01/01/2000

Richard G. Minicus

Corporate Officer/Principal

30/12/1998

John T. Boris

Corporate Officer/Principal

02/01/1988

01/01/1998

Dilip J. Mehta

Corporate Officer/Principal

01/01/1982

Mark A. Braman

Corporate Officer/Principal

01/01/1984

01/01/1996

Jonathan R. McGrath

Chief Tech/Sci/R&D Officer

01/01/1990

01/01/1995

Henrik Rasmussen

Corporate Officer/Principal

01/01/1989

01/12/1994

Andrew B. McCormick

Public Communications Contact

01/01/1993

Robert Cohen

Corporate Officer/Principal

01/01/1981

01/01/1992

Gene Clapp

Corporate Officer/Principal

31/12/1987

Sylvia Montero

Human Resources Officer

01/01/1978

Theodore Matthew Thome

Corporate Officer/Principal

Jay Lichter

Corporate Officer/Principal

Albert Michael Davis

Corporate Officer/Principal

Malcolm Kahn

Comptroller/Controller/Auditor	-	-
Sales & Marketing	-	-

Jean-Michel Hotton

Corporate Officer/Principal

Peter Rost

Corporate Officer/Principal

Daniel Cushing

Corporate Officer/Principal

John Nicastro

Sales & Marketing

Mike E. Pape

Corporate Officer/Principal

Robert H. Driver

Corporate Officer/Principal

Andrew Hertzmark

Corporate Officer/Principal

Robert W. Norton

Corporate Officer/Principal

Shreya Prudlo

Public Communications Contact

Ali Shirazi

Corporate Officer/Principal

Gabriela G. Cezar

Corporate Officer/Principal

John W. Mitchell

Corporate Officer/Principal

Raul E. Kohan

Comptroller/Controller/Auditor

Tyana Kurtz

Sales & Marketing

David McGibney

Corporate Officer/Principal

Alan Lang

Corporate Officer/Principal

Steve Kennedy

Corporate Officer/Principal

Donald R. Sellers

Corporate Officer/Principal

Dennis J. Block

Corporate Officer/Principal

Howard Zauberman

Corporate Officer/Principal

Pierre E. G. Etienne

Chief Operating Officer

Robert L. Mallett

Public Communications Contact

Michael Petrarca

Corporate Officer/Principal

Stephen Arneric

Corporate Officer/Principal

James W. Larson

Human Resources Officer

Nancy Ramamurthi

Corporate Officer/Principal

Leonard C. Stephens

Human Resources Officer

Richard A. Lotti

Corporate Officer/Principal

Anup Arora

Corporate Officer/Principal

Andrew McDonald

Corporate Officer/Principal

Charles L. Hardwick

Public Communications Contact

01/01/1966

Distribución por Edad de los Ejecutivos

Paridad de género

Hombre	39
Mujer	10

De los cuales Comité Ejecutivo

Hombre	12
Mujer	5

De los cuales Directores

Hombre	13
Mujer	1

ESG MSCI

ESG

Medio ambiente

Social

Gobernanza

Polémica

Pfizer, Inc. es el primer grupo farmacéutico mundial. Las ventas netas se desglosan por familias de productos de la siguiente manera: - productos de atención primaria (52,3%): medicamentos utilizados en medicina interna, vacunas, medicamentos para la prevención y el tratamiento de la Covid-19, antivirales, productos basados en ARNm, etc.; - productos de atención especializada (25,6%): medicamentos utilizados en inmunología, en hospitales y para el tratamiento de enfermedades raras, antiinflamatorios, etc; - productos oncológicos (19,9%); - otros (2,2%). Las ventas netas se distribuyen geográficamente del siguiente modo: Estados Unidos (42,3%), Europa (21,9%) y otros (33,8%).

Empleados

88.000

Sector

Farmacéuticos

Agenda

04/02/2025 - Q4 2024 Publicación de resultados

Más información sobre la empresa